The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Activation of p53 by MEG3 Non-coding RNA
Open accessAbstract
MEG3 is a maternally expressed imprinted gene suggested to function as a non-coding RNA. Our previous studies suggest that MEG3 has a function of tumor suppression. The tumor suppressor p53 plays a central role in tumor suppression and mediates the functions of many other tumor suppressors. Therefore, we hypothesized that MEG3 functions through activation of p53. We found that transfection of expression constructs for MEG3 and its isoforms results in a significant increase in p53 protein levels and dramatically stimulates p53-dependent transcription from a p53-responsive promoter. Using this as the functional assay, we demonstrated that the open reading frames encoded by MEG3 transcripts are not required for MEG3 function, and the folding of MEG3 RNA is critical to its function, supporting the concept that MEG3 functions as a non-coding RNA. We further found that MEG3 stimulates expression of the growth differentiation factor 15 (GDF15) by enhancing p53 binding to the GDF15 gene promoter. Interestingly, MEG3 does not stimulate p21(CIP1) expression, suggesting that MEG3 can regulate the specificity of p53 transcriptional activation. p53 degradation is mainly mediated by the mouse double minute 2 homolog (MDM2). We found that MDM2 levels were down-regulated in cells transfected with MEG3, suggesting that MDM2 suppression contributes at least in part to p53 accumulation induced by MEG3. Finally, we found that MEG3 is able to inhibit cell proliferation in the absence of p53. These data suggest that MEG3 non-coding RNA may function as a tumor suppressor, whose action is mediated by both p53-dependent and p53-independent pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Normand, G., Hemmati, P., Verdoodt, B., von Haefen, C., Wendt, J., Güner, D., May, E., Dörken, B., & Daniel, P. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412330200 · Cited by 45
RetractedMfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mathews, D. H., Sabina, J., Zuker, M., & Turner, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2700 · Cited by 3,795
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Mattick, J. S., & Makunin, I. V. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl046 · Cited by 2,453
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,177
Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs
Matera, A. G., Terns, R. M., & Terns, M. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2124 · Cited by 877
Regulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex
Lanz, R. B., McKenna, N. J., Onate, S. A., Albrecht, U., Wong, J., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1999) · Cell · doi:10.1016/s0092-8674(00)80711-4 · Cited by 792
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
Brooks, C. L., & Gu, W. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00003-6 · Cited by 742
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664
Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function
Pang, K. C., Frith, M. C., & Mattick, J. S. (2006) · Trends in Genetics · doi:10.1016/j.tig.2005.10.003 · Cited by 656
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Tumour-suppressor activity of H19 RNA
Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., & Tycko, B. (1993) · Nature · doi:10.1038/365764a0 · Cited by 630
Freeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00021-7 · Cited by 515
Small regulatory RNAs in mammals
Mattick, J. S., & Makunin, I. V. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi101 · Cited by 512
Lin, S.-P., Youngson, N., Takada, S., Seitz, H., Reik, W., Paulsen, M., Cavaille, J., & Ferguson-Smith, A. C. (2003) · Nature Genetics · doi:10.1038/ng1233 · Cited by 470
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
Zhang, X., Zhou, Y., Mehta, K. R., Danila, D. C., Scolavino, S., Johnson, S. R., & Klibanski, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030222 · Cited by 435
Self-citationAshcroft, M., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203012 · Cited by 415
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Baek, S. J., Kim, K.-S., Nixon, J. B., Wilson, L. C., & Eling, T. E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09260-5 · Cited by 401
Miyoshi, N., Wagatsuma, H., Wakana, S., Shiroishi, T., Nomura, M., Aisaka, K., Kohda, T., Surani, M. A., Kaneko‐Ishino, T., & Ishino, F. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00320.x · Cited by 384
BRCA1 regulates p53-dependent gene expression
Ouchi, T., Monteiro, A. N. A., August, A., Aaronson, S. A., & Hanafusa, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2302 · Cited by 375
The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes.
Marechal, V, Elenbaas, B., Piette, J., Nicolas, J. C., & Levine, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7414 · Cited by 318
Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S., Ke, H. Z., Qi, H., Owen, T. A., & Thompson, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13760 · Cited by 289
Wylie, A. A. (2000) · Genome Research · doi:10.1101/gr.161600 · Cited by 275
Li, P.-X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., & Klamut, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909580199 · Cited by 254
Tan, M., Wang, Y., Guan, K., & Sun, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.109 · Cited by 252
Self-citationp53 Stabilization and Transactivation by a von Hippel-Lindau Protein
Roe, J.-S., Kim, H., Lee, S.-M., Kim, S.-T., Cho, E.-J., & Youn, H.-D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.006 · Cited by 237
PLAB, a novel placental bone morphogenetic protein
Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y., & Lu, L. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00122-x · Cited by 231
Takada, S., Tevendale, M., Baker, J., Georgiades, P., Campbell, E., Freeman, T., Johnson, M. H., Paulsen, M., & Ferguson-Smith, A. C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00704-1 · Cited by 223
Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta
Lawton, L. N., Bonaldo, M. D. F., Jelenc, P. C., Qiu, L., Baumes, S. A., Marcelino, R. A., de Jesus, G. M., Wellington, S., Knowles, J. A., Warburton, D., et al. (1997) · Gene · doi:10.1016/s0378-1119(97)00485-x · Cited by 207
Zhao, J., Dahle, D., Zhou, Y., Zhang, X., & Klibanski, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1848 · Cited by 207
Self-citationp53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase
Teodoro, J. G., Parker, A. E., Zhu, X., & Green, M. R. (2006) · Science · doi:10.1126/science.1126391 · Cited by 195
Baek, S. J., Wilson, L. C., & Eling, T. E. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.425 · Cited by 194
Baek, S. J., Okazaki, R., Lee, S.-H., Martinez, J., Kim, J.-S., Yamaguchi, K., Mishina, Y., Martin, D. W., Shoieb, A., Mcentee, M. F., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.015 · Cited by 175
Albertoni, M., Shaw, P. H., Nozaki, M., Godard, S., Tenan, M., Hamou, M.-F., Fairlie, D. W., Breit, S. N., Paralkar, V. M., de Tribolet, N., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205610 · Cited by 174
Baek, S. J., Kim, J.-S., Moore, S. M., Lee, S.-H., Martinez, J., & Eling, T. E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005108 · Cited by 162
BRCA1-associated growth arrest is RB-dependent
Aprelikova, O. N., Fang, B. S., Meissner, E. G., Cotter, S., Campbell, M., Kuthiala, A., Bessho, M., Jensen, R. A., & Liu, E. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11866 · Cited by 158
Schuster-Gossler, K., Bilinski, P., Sado, T., Ferguson‐Smith, A. C., & Gossler, A. (1998) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199806)212:2<214::aid-aja6>3.0.co;2-k · Cited by 157
Astuti, D., Latif, F., Wagner, K. J., Gentle, D., Cooper, W. N., Catchpoole, D. R., Grundy, R. G., Ferguson‐Smith, A. C., & Maher, E. R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602478 · Cited by 136
NSAID Activated Gene (NAG-1), a Modulator of Tumorigenesis
Eling, T. E., Baek, S. J., Shim, M., & Lee, C. H. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.6.649 · Cited by 123
Wilson, L. C., Baek, S. J., Call, A., & Eling, T. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11173 · Cited by 120
PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
Paramio, J. M., Navarro, M., Segrelles, C., Gómez‐Casero, E., & Jorcano, J. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203151 · Cited by 117
Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis
Hemmati, P., Gillissen, B. F., von Haefen, C., Wendt, J., Stärck, L., Güner, D., Dörken, B., & Daniel, P. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205458 · Cited by 109
Regulation of the p53 transcriptional activity
Liu, G., & Chen, X. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 102
Lim, J. H., Park, J. W., Min, D. S., Chang, J., Lee, Y. H., Park, Y. B., Choi, K. S., & Kwon, T. K. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0576-9 · Cited by 95
DNA Damage-induced Inhibition of Securin Expression Is Mediated by p53
Zhou, Y., Mehta, K. R., Choi, A., Scolavino, S., & Zhang, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203793200 · Cited by 91
Self-citationA p53-type response element in the GDF15 promoter confers high specificity for p53 activation
Osada, M., Park, H. L., Park, M. J., Liu, J.-W., Wu, G., Trink, B., & Sidransky, D. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.089 · Cited by 89
Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53
Kim, H., Kwak, N., Lee, J., Choi, B. H., Lim, Y., Ko, Y. J., Kim, Y.-H., Huh, P., Lee, K.-H., Rha, H. K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305526200 · Cited by 74
Self-citationAlternative splicing and imprinting control of the Meg3/Gtl2-Dlk1 locus in mouse embryos
Croteau, S., Charron, M.-C., Latham, K. E., & Naumova, A. K. (2003) · Mammalian Genome · doi:10.1007/s00335-002-2244-x · Cited by 31
Insights into Selective Activation of p53 DNA Binding by c-Abl
Wei, G., Li, A. G., & Liu, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409522200 · Cited by 22
(1995) · PubMed
Cited by
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., et al. (2012) · Genome Research · doi:10.1101/gr.132159.111 · Cited by 5,061
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Long Noncoding RNAs in Cancer Pathways
Schmitt, A. M., & Chang, H. Y. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.010 · Cited by 2,992
Long Noncoding RNA and Cancer: A New Paradigm
Bhan, A., Soleimani, M., & Mandal, S. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2634 · Cited by 2,861
The landscape of long noncoding RNAs in the human transcriptome
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3192 · Cited by 2,738
Metadata
- Authors
- Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J., Weng, C., & Klibanski, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 34
- Pages
- 24731-24742
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083033504
- Cited by
- 653
- References
- 57
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.